Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study

Aim. To study the long-term effect of complex therapy with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, and systolic cardiac function in patients with stable coronary artery disease (CAD) complicated by heart failure (HF).Material and methods. Open randomized stu...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Lishuta, O. A. Slepova, N. S. Nikolaeva, E. V. Privalova, Yu. N. Belenkov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2024-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5886
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839576517613453312
author A. S. Lishuta
O. A. Slepova
N. S. Nikolaeva
E. V. Privalova
Yu. N. Belenkov
author_facet A. S. Lishuta
O. A. Slepova
N. S. Nikolaeva
E. V. Privalova
Yu. N. Belenkov
author_sort A. S. Lishuta
collection DOAJ
description Aim. To study the long-term effect of complex therapy with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, and systolic cardiac function in patients with stable coronary artery disease (CAD) complicated by heart failure (HF).Material and methods. Open randomized study EXCEL (NCT05913778) included 118 patients with verified stable CAD complicated by NYHA class II-III HF with reduced or mildly reduced ejection fraction (EF). The patients were randomized into group 1 (n=59) who received optimal therapy and EECP (35 hours, 2 courses per year) or group 2 (n=59), who recived optimal drug therapy and EECP (35 hours, 1 course per year). All patients underwent a 6-minute walk test (6MWT) at baseline, 12, 24 and 36 months, the assessment of clinical status, Minnesota Living with Heart Failure Questionnaire (MLHFQ), N-terminal pro-brain natriuretic peptide (NTproBNP) levels, LVEF and clinical outcomes.Results. In both groups, we revealed an improvement of HF class (average HF class after 36 months decreased in the 1st group from 2,40 to 1,86 (p<0,001), and in the 2nd group from 2,37 to 2,17 (p<0,001)) and clinical status of patients. A significant increase in 6MWT distance after 24 months was revealed in both groups — in group 1 by 59,4% (95% confidence interval (CI) 36,9-76,8), and in group 2 — by 34,3% (95% CI 26,7-40,1). The proportions of patients with an increase in 6MWD distance >20% in groups 1 and 2 after 36 months were 100% (n=59) and 79,7% (n=47) (p<0,001), respectively. There was a significant decrease in the MLHFQ score after 36 months in the 1st group by 43,8% (95% CI 40,5-47,1), and in the 2nd group by 30,0% (95% CI 26,4-33,6), NT-proBNP decrease, as well as an increase in LVEF. There were no deaths in group 1, while in group 2, mortality was 3,4%.Conclusion. A 36-month follow-up of patients with CAD complicated by HF receiving EECP revealed stable improvements in exercise tolerance, quality of life, systolic cardiac function, more pronounced in the group with 2 courses of EECP per year, as well as a decrease in the incidence of adverse outcomes.
format Article
id doaj-art-15548d8ab8ec44d68a9710f26d5c0513
institution Matheson Library
issn 1560-4071
2618-7620
language Russian
publishDate 2024-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-15548d8ab8ec44d68a9710f26d5c05132025-08-04T13:00:32Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202024-06-0129610.15829/1560-4071-202458864091Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL studyA. S. Lishuta0O. A. Slepova1N. S. Nikolaeva2E. V. Privalova3Yu. N. Belenkov4I. M. Sechenov First Moscow State Medical UniversityI. M. Sechenov First Moscow State Medical UniversityI. M. Sechenov First Moscow State Medical UniversityI. M. Sechenov First Moscow State Medical UniversityI. M. Sechenov First Moscow State Medical UniversityAim. To study the long-term effect of complex therapy with enhanced external counterpulsation (EECP) on exercise tolerance, quality of life, and systolic cardiac function in patients with stable coronary artery disease (CAD) complicated by heart failure (HF).Material and methods. Open randomized study EXCEL (NCT05913778) included 118 patients with verified stable CAD complicated by NYHA class II-III HF with reduced or mildly reduced ejection fraction (EF). The patients were randomized into group 1 (n=59) who received optimal therapy and EECP (35 hours, 2 courses per year) or group 2 (n=59), who recived optimal drug therapy and EECP (35 hours, 1 course per year). All patients underwent a 6-minute walk test (6MWT) at baseline, 12, 24 and 36 months, the assessment of clinical status, Minnesota Living with Heart Failure Questionnaire (MLHFQ), N-terminal pro-brain natriuretic peptide (NTproBNP) levels, LVEF and clinical outcomes.Results. In both groups, we revealed an improvement of HF class (average HF class after 36 months decreased in the 1st group from 2,40 to 1,86 (p<0,001), and in the 2nd group from 2,37 to 2,17 (p<0,001)) and clinical status of patients. A significant increase in 6MWT distance after 24 months was revealed in both groups — in group 1 by 59,4% (95% confidence interval (CI) 36,9-76,8), and in group 2 — by 34,3% (95% CI 26,7-40,1). The proportions of patients with an increase in 6MWD distance >20% in groups 1 and 2 after 36 months were 100% (n=59) and 79,7% (n=47) (p<0,001), respectively. There was a significant decrease in the MLHFQ score after 36 months in the 1st group by 43,8% (95% CI 40,5-47,1), and in the 2nd group by 30,0% (95% CI 26,4-33,6), NT-proBNP decrease, as well as an increase in LVEF. There were no deaths in group 1, while in group 2, mortality was 3,4%.Conclusion. A 36-month follow-up of patients with CAD complicated by HF receiving EECP revealed stable improvements in exercise tolerance, quality of life, systolic cardiac function, more pronounced in the group with 2 courses of EECP per year, as well as a decrease in the incidence of adverse outcomes.https://russjcardiol.elpub.ru/jour/article/view/5886enhanced external counterpulsationcoronary artery diseaseheart failureexercise tolerancequality of life
spellingShingle A. S. Lishuta
O. A. Slepova
N. S. Nikolaeva
E. V. Privalova
Yu. N. Belenkov
Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
Российский кардиологический журнал
enhanced external counterpulsation
coronary artery disease
heart failure
exercise tolerance
quality of life
title Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
title_full Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
title_fullStr Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
title_full_unstemmed Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
title_short Long-term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure: data from the EXCEL study
title_sort long term effects of enhanced external counterpulsation in the management of patients with coronary artery disease complicated by heart failure data from the excel study
topic enhanced external counterpulsation
coronary artery disease
heart failure
exercise tolerance
quality of life
url https://russjcardiol.elpub.ru/jour/article/view/5886
work_keys_str_mv AT aslishuta longtermeffectsofenhancedexternalcounterpulsationinthemanagementofpatientswithcoronaryarterydiseasecomplicatedbyheartfailuredatafromtheexcelstudy
AT oaslepova longtermeffectsofenhancedexternalcounterpulsationinthemanagementofpatientswithcoronaryarterydiseasecomplicatedbyheartfailuredatafromtheexcelstudy
AT nsnikolaeva longtermeffectsofenhancedexternalcounterpulsationinthemanagementofpatientswithcoronaryarterydiseasecomplicatedbyheartfailuredatafromtheexcelstudy
AT evprivalova longtermeffectsofenhancedexternalcounterpulsationinthemanagementofpatientswithcoronaryarterydiseasecomplicatedbyheartfailuredatafromtheexcelstudy
AT yunbelenkov longtermeffectsofenhancedexternalcounterpulsationinthemanagementofpatientswithcoronaryarterydiseasecomplicatedbyheartfailuredatafromtheexcelstudy